Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Expert Opinion on Investigational Drugs|March 23, 2019
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?Stefano Cavalieri, Francesca Platini, Cristiana Bergamini, et al.
Future Oncology (London, England)|May 7, 2020
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE studyPaolo Bossi, Ketty Peris, Piergiacomo Calzavara-Pinton, et al.
Frontiers in Oncology|February 3, 2023
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patientsStefano Cavalieri, Imperia Nuzzolese, Arianna Ottini, et al.
Tumori|May 2, 2018
Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancersCarlo Resteghini, Federica Perrone, Rosalba Miceli, et al.
Oncotarget|December 10, 2017
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target?Carlo Resteghini, Salvatore Alfieri, Pasquale Quattrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2021
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II TrialLaura D Locati, Stefano Cavalieri, Cristiana Bergamini, et al.
Frontiers in Oncology|December 11, 2023
Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patientsCristiana Bergamini, Stefano Cavalieri, Carlo Resteghini, et al.
Critical Reviews in Oncology/Hematology|May 15, 2022
Tissue and circulating PD-L2: moving from health and immune-mediated diseases to head and neck oncologyElena Muraro, Rebecca RomanĂ², Giuseppe Fanetti, et al.
Pageof 9